Chemesis International Inc. Subsidiary, Natural Ventures PR, LLC, to Remain Operational During COVID-19 Pandemic
Chemesis International Inc. Announces Closing of CDN $5,000,000 Private Placement and Settlement of Debt
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
